In the pursuit of precision medicine, Therapeutic Drug Carrier Systems (TDCS) emerge as instrumental players, transforming the landscape of drug delivery. Precision medicine seeks to customize treatments based on individual patient characteristics, and TDCS aligns seamlessly with this vision. TDCS leverages cutting-edge technologies to encapsulate therapeutic agents, ensuring targeted and controlled drug release. Nanoparticles, liposomes, and micelles are among the sophisticated carriers employed to navigate the intricate pathways of precision medicine.
The precision achieved with TDCS is particularly advantageous in oncology, where targeted delivery minimizes damage to healthy tissues and enhances the therapeutic impact on cancer cells. Moreover, the use of nanocarriers allows for the delivery of a diverse range of drugs, from chemotherapy agents to gene therapies. Beyond oncology, TDCS holds promise in treating various diseases, including neurological disorders and inflammatory conditions. The ability to tailor drug delivery to specific tissues or cells enhances the therapeutic potential while minimizing side effects. As the era of precision medicine unfolds, Therapeutic Drug Carrier Systems stand at the forefront, offering a roadmap for personalized and effective drug delivery strategies.
Thomas J Webster
Hebei University of Technology, United States
Hossein Hosseinkhani
Innovation Center for Advanced Technology, Matrix, Inc., United States
Hai Feng Ji
Drexel University, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Azzedine Bensalem
Long Island University, United States
Robert Buenker
Wuppertal University, Germany
Rafal Kozubski
Jagiellonian University in Krakow, Poland
Sylwia Wcislik
Kielce University of Technology, Poland
Raman Singh
Monash University-Clayton Campus, Australia
Michael I Tribelsky
Moscow State University, Russian FederationSubmit your abstract Today
Title : Circumventing challenges in developing CVD graphene coating on mild steel: A disruptive approach to remarkable/durable corrosion resistance
Raman Singh, Monash University-Clayton Campus, Australia
Title : Highlighting recent advancements in electromagnetic field subwavelength tailoring using nanoparticle resonant light scattering and related topics
Michael I Tribelsky, Moscow State University, Russian Federation
Title : The impact of nanomedicine: 30,000 orthopedic nano implants with no failures and still counting
Thomas J Webster, Hebei University of Technology, United States
Title : Logistic-modified mathematical model for tumor growth treated with nanosized cargo delivery system
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Current and future of red and black phosphorus nanomaterials
Hai Feng Ji, Drexel University, United States
Title : Azodye photoaligned nanolayers for liquid crystal: New trends
Vladimir G Chigrinov, Hong Kong University of Science and Technology, Hong Kong
Title : Atomistic simulation of chemical ordering phenomena in nanostructured intermetallics
Rafal Kozubski, Jagiellonian University in Krakow, Poland
Title : The enhanced cytotoxic effect of curcumin on leukemic stem cells via CD123-targeted nanoparticles
Wariya Nirachonkul, Chiang Mai University, Thailand
Title : Efficiency of nanoparticles (Micromage-B) in the complex treatment of multiple sclerosis
Andrey Belousov, Kharkiv National Medical University, Ukraine
Title : Innovative method of nanotechnology application in the complex treatment of multiple sclerosis
Andrey Belousov, Kharkiv National Medical University, Ukraine